Skip to content
DraconiticResearch
Search Sources API
220,430 studies31 sourcesUpdated 58 min ago
Peer-reviewedLicence not statedBritish Journal of Cancer

CD39+CD103+CD8+ T cells enhance neoadjuvant chemoimmunotherapy efficacy in head and neck squamous cell carcinoma

7 more authors
5 affiliations
  1. 1Department of Oral and Maxillofacial Surgery, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, China
  2. 2Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Medical Research Center, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
  3. 3Department of Stomatology, Shenzhen Bao’an Shiyan People’s Hospital, Shenzhen, China
  4. 4College & Hospital of Stomatology, Anhui Medical University, Key Lab. of Oral Diseases Research of Anhui Province, Hefei, China
  5. 5Clinical college of Xiangnan University, Chenzhou, China

Related

  1. Efficacy comparison of neoadjuvant chemotherapy, chemoradiotherapy, and chemoimmunotherapy in resectable esophageal squamous cell carcinoma: short- and long-term outcomes from a propensity score-matched analysis
    Hai Zhang, Yujing Liang, Chaolin Li +3
    Frontiers in medicinePeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMCPMC
  2. Response-Adapted Postoperative Therapy Following Neoadjuvant Chemoimmunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: a phase II trial
    Yu Qian, Liu Hu, Liang Jiang +8
    Nature CommunicationsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicinePMC
  3. Lymph Node Regression Improves Prognostic Stratification in Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Chemoimmunotherapy: A Multicenter Retrospective Cohort Study.
    Jian Zheng, Wenbin Shen, Jianzhong Cao +13
    MedCommPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
  4. Postoperative radiotherapy versus systemic therapy alone for locally advanced esophageal squamous cell carcinoma following neoadjuvant chemoimmunotherapy
    Zongqian Yuan, Junfeng Zhao, Chunhui Li +5
    Frontiers in OncologyPeer-reviewedCC BY 4.0OncologyFrontiersCrossref
  5. Discordant Primary Tumor and Nodal Response After Neoadjuvant Chemoimmunotherapy Identifies an Adverse Postoperative Subgroup in Esophageal Squamous Cell Carcinoma
    Yuxian Qian, Yuting Ren, Zhiyun Xu +8
    Cancer MedicinePeer-reviewedCC BY-NC-ND 4.0Full textSurgery & anaesthesiaPMC
BibTeX
@article{chen2026cd39cd103cd8,
  title = {{CD39+CD103+CD8+ T cells enhance neoadjuvant chemoimmunotherapy efficacy in head and neck squamous cell carcinoma}},
  author = {Suling Chen and Yupeng Wu and Guangxin Rao and Weihao Tong and Jingbin Huo and Guoxin Huang and Wenhao Sun and Songjiu Li and Chenchang Li and Shengguo Hu and Yingnan Ma and Ruiqi Zhu and Diya Wang and Meijuan Zhang and Qi’an Chen and Xiao Tan and Jinsong Li and Zhaoyu Lin and Bowen Li},
  journal = {British Journal of Cancer},
  year = {2026},
  month = aug,
  doi = {10.1038/s41416-026-03588-7},
  url = {https://doi.org/10.1038/s41416-026-03588-7},
}
RIS
TY  - JOUR
TI  - CD39+CD103+CD8+ T cells enhance neoadjuvant chemoimmunotherapy efficacy in head and neck squamous cell carcinoma
AU  - Suling Chen
AU  - Yupeng Wu
AU  - Guangxin Rao
AU  - Weihao Tong
AU  - Jingbin Huo
AU  - Guoxin Huang
AU  - Wenhao Sun
AU  - Songjiu Li
AU  - Chenchang Li
AU  - Shengguo Hu
AU  - Yingnan Ma
AU  - Ruiqi Zhu
AU  - Diya Wang
AU  - Meijuan Zhang
AU  - Qi’an Chen
AU  - Xiao Tan
AU  - Jinsong Li
AU  - Zhaoyu Lin
AU  - Bowen Li
PY  - 2026
DA  - 2026/08/20
JO  - British Journal of Cancer
DO  - 10.1038/s41416-026-03588-7
UR  - https://doi.org/10.1038/s41416-026-03588-7
SN  - 0007-0920
SN  - 1532-1827
ER  -